{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:39:52Z","timestamp":1792600792203,"version":"4.5.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aimed to appraise 11 currently available guidelines for ANCA-associated vasculitis (AAV), identify potential gaps, and provide recommendations for improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The guidelines were appraised using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument consisting of 23 appraisal criteria\/items across six domains (D). Four reviewers independently appraised guidelines and scaled domain scores were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The average score of all guidelines was 4.5\u00a0\u00b1\u00a00.8 out of 7.0. Agreement between the reviewers was excellent. British Society for Rheumatology 2025 guidelines scored highest (5.8\/7.0), being the only guideline unanimously recommended for use. In \u2018D1\/Scope and purpose\u2019, all guidelines achieved high scores. In \u2018D2\/Stakeholder involvement\u2019, major gaps were identified in the inclusion of the views and preferences of the target population (2c), with few guidelines including patient representatives, addressing patient participation, or considering patient views. In \u2018D3\/Rigour of development\u2019, all but two guidelines received high scores. Implementation of the procedure for updating the guidelines (3 h) and for external review (3 g) was addressed poorly. In \u2018D4\/Clarity of presentation\u2019, all guidelines except one received a high score. \u2018D5\/Applicability\u2019 had the lowest scores due to gaps in the criteria for monitoring\/auditing guideline implementation (5d), resource\/cost implications (5c), lack of advice\/tools for implementation (5a), and inadequate addressing of facilitators\/barriers in guideline application (5a). \u2018D6\/Editorial independence\u2019 was addressed well.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Several aspects of AAV guidelines could be improved, including the inclusion of patient views and preferences, the processes for translating guidelines into clinical practice, and clearer criteria for monitoring guideline implementation and uptake.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag317","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:48:54Z","timestamp":1791546534000},"source":"Crossref","is-referenced-by-count":0,"title":["A critical appraisal of guidelines and recommendations for the management of ANCA-associated vasculitis"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9642-4075","authenticated-orcid":false,"given":"Vanja","family":"Ivkovi\u0107","sequence":"first","affiliation":[{"name":"Department of Health, Medicine and Caring Sciences, Link\u00f6ping University , Link\u00f6ping ,","place":["Sweden"]},{"name":"Department of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb , Zagreb ,","place":["Croatia"]},{"name":"Faculty of Health Studies, University of Rijeka , Rijeka ,","place":["Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejin","family":"Park","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0756-3151","authenticated-orcid":false,"given":"Lauren","family":"Floyd","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust , Preston, Lancashire ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Seo","family":"Kwon","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Bruchfeld","sequence":"additional","affiliation":[{"name":"Department of Health, Medicine and Caring Sciences, Link\u00f6ping University , Link\u00f6ping ,","place":["Sweden"]},{"name":"Department of Renal Medicine, Karolinska University Hospital and CLINTEC Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kronbichler","sequence":"additional","affiliation":[{"name":"Department of Health, Medicine and Caring Sciences, Link\u00f6ping University , Link\u00f6ping ,","place":["Sweden"]},{"name":"Department of Internal Medicine IV, Nephrology and Hypertension, Medical University Innsbruck , Innsbruck ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2326-1820","authenticated-orcid":false,"given":"Jae Il","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yonsei University College of Medicine , Seoul ,","place":["Korea"]},{"name":"The Center for Medical Education Training and Professional Development in Yonsei-Donggok Medical Education Institute , Seoul ,","place":["Korea"]},{"name":"Severance Underwood Meta-research Center, Institute of Convergence Science, Yonsei University , Seoul ,","place":["Korea"]},{"name":"Section of Digestive Diseases, Department of Medicine, Yale School of Medicine , New Haven, CT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"2026102111490549700_bib1","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines","year":"2011"},{"key":"2026102111490549700_bib2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/qshc.2008.028043","article-title":"Effects of evidence-based clinical practice guidelines on quality of care: a systematic review","volume":"18","author":"Lugtenberg","year":"2009","journal-title":"Qual Safety Health Care"},{"key":"2026102111490549700_bib3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12913-022-08975-3","article-title":"Approaches to clinical guideline development in healthcare: a scoping review and document analysis","volume":"23","author":"De\u00a0Leo","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"2026102111490549700_bib4","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.injury.2022.01.047","article-title":"Clinical practice guidelines: the good, the bad, and the ugly","volume":"54","author":"Guerra-Farfan","year":"2023","journal-title":"Injury"},{"key":"2026102111490549700_bib5","volume-title":"Improving Healthcare Quality in Europe: Characteristics, Effectiveness and Implementation of Different Strategies","author":"Panteli","year":"2019"},{"key":"2026102111490549700_bib6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12961-022-00815-4","article-title":"Strategies for the implementation of clinical practice guidelines in public health: an overview of systematic reviews","volume":"20","author":"Pereira","year":"2022","journal-title":"Health Res Policy Sys"},{"key":"2026102111490549700_bib7","doi-asserted-by":"publisher","first-page":"e001166","DOI":"10.1136\/bmjdrc-2019-001166","article-title":"Influence of guideline adherence and parameter control on the clinical outcomes in patients with diabetic nephropathy","volume":"8","author":"Lu","year":"2020","journal-title":"BMJ Open Diab Res Care"},{"key":"2026102111490549700_bib8","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1001\/jama.2013.281334","article-title":"Enhancing physicians\u2019 use of clinical guidelines","volume":"310","author":"Pronovost","year":"2013","journal-title":"JAMA"},{"key":"2026102111490549700_bib9","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.ekir.2018.05.007","article-title":"Comparisons of guidelines and recommendations on managing antineutrophil cytoplasmic antibody-associated vasculitis","volume":"3","author":"Geetha","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2026102111490549700_bib10","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/ndt\/gfad237","article-title":"ANCA-associated vasculitis\u2014treatment standard","volume":"39","author":"Chalkia","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026102111490549700_bib11","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.jclinepi.2010.07.001","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"63","author":"Brouwers","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"2026102111490549700_bib12","doi-asserted-by":"publisher","first-page":"e82915","DOI":"10.1371\/journal.pone.0082915","article-title":"Appraisal tools for clinical practice guidelines: a systematic review","volume":"8","author":"Siering","year":"2013","journal-title":"PLoS One"},{"key":"2026102111490549700_bib13","doi-asserted-by":"publisher","first-page":"E472","DOI":"10.1503\/cmaj.091716","article-title":"Development of the AGREE II, part 2: assessment of validity of items and tools to support application","volume":"182","author":"Brouwers","year":"2010","journal-title":"Can Med Assoc J"},{"key":"2026102111490549700_bib14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1503\/cmaj.091714","article-title":"Development of the AGREE II, part 1: performance, usefulness and areas for improvement","volume":"182","author":"Brouwers","year":"2010","journal-title":"Can Med Assoc J"},{"key":"2026102111490549700_bib15","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody\u2013Associated Vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2026102111490549700_bib16","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1093\/rheumatology\/keaf240","article-title":"The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis","volume":"64","author":"Biddle","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026102111490549700_bib17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3899\/jrheum.200721","article-title":"CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update","volume":"48","author":"Mendel","year":"2021","journal-title":"J Rheumatol"},{"key":"2026102111490549700_bib18","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1093\/rheumatology\/kead087","article-title":"CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum","volume":"62","author":"Turgeon","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2026102111490549700_bib19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026102111490549700_bib20","doi-asserted-by":"publisher","first-page":"103647","DOI":"10.1016\/j.autrev.2024.103647","article-title":"Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis","volume":"23","author":"Dhooria","year":"2024","journal-title":"Autoimmun Rev"},{"key":"2026102111490549700_bib21","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.kint.2023.10.008","article-title":"KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"2026102111490549700_bib22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/mr\/road081","article-title":"Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: the 2023 update\u2014secondary publication","volume":"34","author":"Sada","year":"2024","journal-title":"Mod Rheumatol"},{"key":"2026102111490549700_bib23","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.1016\/S2665-9913(23)00128-5","article-title":"Pan American League of Associations for Rheumatology Guidelines for the treatment of ANCA-associated vasculitis","volume":"5","author":"Magri","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"2026102111490549700_bib24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13023-020-01621-3","article-title":"French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)","volume":"15","author":"Terrier","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2026102111490549700_bib25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.nefroe.2025.01.001","article-title":"Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitis","volume":"45","author":"Morales","year":"2025","journal-title":"Nefrolog\u00eda (Engl Ed)"},{"key":"2026102111490549700_bib26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jclinepi.2017.12.009","article-title":"Systematic review of current guideline appraisals performed with the Appraisal of Guidelines for Research & Evaluation II instrument-a third of AGREE II users apply a cut-off for guideline quality","volume":"95","author":"Hoffmann-E\u00dfer","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"2026102111490549700_bib27","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1136\/qshc.2010.042077","article-title":"The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies","volume":"19","author":"Alonso-Coello","year":"2010","journal-title":"BMJ Qual Saf"},{"key":"2026102111490549700_bib28","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1001\/jama.281.20.1900","article-title":"Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature","volume":"281","author":"Shaneyfelt","year":"1999","journal-title":"JAMA"},{"key":"2026102111490549700_bib29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.amjcard.2023.06.052","article-title":"A systematic critical appraisal of clinical practice guidelines in heart failure using the AGREE II tool","volume":"202","author":"Sephien","year":"2023","journal-title":"Am J Cardiol"},{"key":"2026102111490549700_bib30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/0141076813486261","article-title":"Guidelines in cardiac clinical practice: evaluation of their methodological quality using the AGREE II instrument","volume":"106","author":"Sabharwal","year":"2013","journal-title":"J R Soc Med"},{"key":"2026102111490549700_bib31","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s10557-024-07605-w","article-title":"Methodological quality of pulmonary arterial hypertension treatment evidence-based guidelines: a systematic review using the AGREE II and AGREE REX tools","volume":"39","author":"Vilela","year":"2024","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026102111490549700_bib32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40256-016-0183-2","article-title":"Clinical Practice Guidelines for Hypertension: evaluation of quality using the AGREE II instrument","volume":"16","author":"Zhang","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"key":"2026102111490549700_bib33","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/dme.14231","article-title":"Management of type 2 diabetes using non-insulin glucose-lowering therapies: a critical appraisal of clinical practice guidelines with the AGREE II instrument","volume":"37","author":"Lam","year":"2020","journal-title":"Diabet Med"},{"key":"2026102111490549700_bib34","doi-asserted-by":"publisher","first-page":"e71382","DOI":"10.1002\/hsr2.71382","article-title":"Clinical Practice Guidelines for the diagnosis of inflammatory bowel disease (IBD): a scoping review","volume":"8","author":"Doyle","year":"2025","journal-title":"Health Sci Rep"},{"key":"2026102111490549700_bib35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/acr.23865","article-title":"Systematic review of recommendations on the use of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and cancer","volume":"72","author":"Lopez-Olivo","year":"2020","journal-title":"Arthritis Care Res"},{"key":"2026102111490549700_bib36","doi-asserted-by":"publisher","first-page":"108610","DOI":"10.1016\/j.lungcan.2025.108610","article-title":"AGREE-II appraisal of lung cancer management clinical practice guidelines by the OPTIMA consortium","volume":"205","author":"Naidu","year":"2025","journal-title":"Lung Cancer"},{"key":"2026102111490549700_bib37","doi-asserted-by":"publisher","first-page":"e17132","DOI":"10.1097\/MD.0000000000017132","article-title":"Quality assessment of kidney cancer clinical practice guidelines using AGREE II instrument: a critical review","volume":"98","author":"Hou","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2026102111490549700_bib38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.euros.2025.07.006","article-title":"Quality Assessment of the European Association of Urology Guidelines Using the AGREE II Tool","volume":"79","author":"Sakalis","year":"2025","journal-title":"Eur Urol Open Sci"},{"key":"2026102111490549700_bib39","doi-asserted-by":"publisher","first-page":"e95369","DOI":"10.1371\/journal.pone.0095369","article-title":"A systematic critical appraisal of non-pharmacological management of rheumatoid arthritis with Appraisal of Guidelines for Research and Evaluation II","volume":"9","author":"Brosseau","year":"2014","journal-title":"PLoS One"},{"key":"2026102111490549700_bib40","article-title":"Current best practices and standards for development of trustworthy CPGs: part II, traversing the process","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Guidelines I of M (US) C on S for DTCP","year":"2011"},{"key":"2026102111490549700_bib41","doi-asserted-by":"publisher","first-page":"q2433","DOI":"10.1136\/bmj.q2433","article-title":"Patient involvement in developing clinical guidelines","volume":"387","author":"Greenhalgh","year":"2024","journal-title":"BMJ"},{"key":"2026102111490549700_bib42","doi-asserted-by":"publisher","first-page":"103135","DOI":"10.1016\/j.eclinm.2025.103135","article-title":"Enhancing health equity considerations in guidelines: health equity extension of the GIN-McMaster Guideline Development Checklist","volume":"82","author":"Dewidar","year":"2025","journal-title":"EClinicalMedicine"},{"key":"2026102111490549700_bib43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2017.05.018","article-title":"Incorporating patients\u2019 views in guideline development: a systematic review of guidance documents","volume":"88","author":"Selva","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"2026102111490549700_bib44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/bmj.323.7305.155","article-title":"When should clinical guidelines be updated?","volume":"323","author":"Shekelle","year":"2001","journal-title":"BMJ"},{"key":"2026102111490549700_bib45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1748-5908-9-3","article-title":"Guidance for updating clinical practice guidelines: a systematic review of methodological handbooks","volume":"9","author":"Vernooij","year":"2014","journal-title":"Implementation Sci"},{"key":"2026102111490549700_bib46","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1001\/jama.286.12.1461","article-title":"Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated?","volume":"286","author":"Shekelle","year":"2001","journal-title":"JAMA"},{"key":"2026102111490549700_bib47","doi-asserted-by":"publisher","first-page":"e008073","DOI":"10.1136\/bmjopen-2015-008073","article-title":"Sustainability of professionals\u2019 adherence to clinical practice guidelines in medical care: a systematic review","volume":"5","author":"Ament","year":"2015","journal-title":"BMJ Open"},{"key":"2026102111490549700_bib48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/mr\/roaf064","article-title":"Concordance between treatment guideline and daily practice in the management of eosinophilic granulomatosis with polyangiitis: a cross-sectional web-questionnaire survey","volume":"36","author":"Watanabe","year":"2025","journal-title":"Mod Rheumatol"},{"key":"2026102111490549700_bib49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1472-6947-5-23","article-title":"The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation","volume":"5","author":"Shiffman","year":"2005","journal-title":"BMC Med Inform Decis Mak"},{"key":"2026102111490549700_bib50","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/bmjebm-2024-113308","article-title":"Development of a generalised tool for evaluating success of clinical practice guidelines implementation (A-GIST)","volume":"30","author":"Zou","year":"2025","journal-title":"BMJ EBM"},{"key":"2026102111490549700_bib51","doi-asserted-by":"publisher","first-page":"111830","DOI":"10.1016\/j.jclinepi.2025.111830","article-title":"What makes a good guideline?\u2014a systematic review and analysis of 120 clinical practice guidelines in orthogeriatric care and related fields using the AGREE II tool","volume":"184","author":"Fotteler","year":"2025","journal-title":"J Clin Epidemiol"},{"key":"2026102111490549700_bib52","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jclinepi.2010.06.005","article-title":"Appraising a tool for guideline appraisal (the AGREE II instrument)","volume":"63","author":"Dans","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"2026102111490549700_bib53","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/ehjqcco\/qcae113","article-title":"Rigour of development of European Society of Cardiology, American College of Cardiology and American Heart Association guidelines over a 12-year period (2013-2024): a systematic review of guidelines","volume":"11","author":"Gomes","year":"2025","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026102111490549700_bib54","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.euros.2024.10.020","article-title":"AGREE II Quality Assessment of National and International Clinical Practice Guidelines on Prostate Cancer Management by the OPTIMA Consortium","volume":"70","author":"Sakalis","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"2026102111490549700_bib55","first-page":"11","article-title":"Report of an international workshop to explore the utility of the AGREE II instrument for appraisal of rare disease guidelines","volume":"2","author":"Hilton\u00a0Boon","year":"2015","journal-title":"Rare Dis Orphan Drugs Int J Publ Health"},{"key":"2026102111490549700_bib56","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-026-03247-1","article-title":"A systematic scoping review on quality criteria for clinical practice guidelines for rare diseases","volume":"15","author":"Hieltjes","year":"2026","journal-title":"Syst Rev"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag317\/71787129\/sfag317.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/10\/sfag317\/71787129\/sfag317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/10\/sfag317\/71787129\/sfag317.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:49:13Z","timestamp":1792597753000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag317\/8898546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag317","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,10,1]]},"article-number":"sfag317"}}